Skip to main content

Site notifications

FERINJECT (Vifor Pharma Pty Ltd)

Product name
FERINJECT
Date registered
Evaluation commenced
Decision date
Approval time
189 (255 working days)
Active ingredients
ferric carboxymaltose
Registration type
EOI
Indication

FERINJECT (solution for injection) is now also indicated for the treatment of iron deficiency when there is a clinical need to deliver iron rapidly.

Help us improve the Therapeutic Goods Administration site